RIKER LAUREN 4
4 · Pacira BioSciences, Inc. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
RIKER LAUREN
Senior Vice President, Finance
Transactions
- Tax Payment
Common Stock
2026-01-02$24.46/sh−159$3,889→ 60,480.242 total - Sale
Common Stock
2026-01-05$24.24/sh−1,416$34,324→ 59,064.242 total
Footnotes (3)
- [F1]Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.
- [F2]Includes 1,075.242 shares of common stock acquired under the issuer's employee stock purchase plan in December 2025.
- [F3]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.